Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease
Muenter, M.D.
Neurology 20(12 Suppl): 6-13
1970
ISSN/ISBN: 0028-3878 PMID: 4921587 Document Number: 26489
Document emailed within 1 workday
Related Documents
Bretlau, P.; Thomsen, J.; Tos, M.; Johnsen, N.J. 1984: Placebo effect in surgery for Meniere's disease: a three-year follow-up study of patients in a double blind placebo controlled study on endolymphatic sac shunt surgery American Journal of Otology 5(6): 558-561Nugteren-Huying, W.M.; van der Schroeff, J.G.; Hermans, J.; Suurmond, D. 1990: Fumaric acid therapy in psoriasis; a double-blind, placebo-controlled study Nederlands Tijdschrift Voor Geneeskunde 134(49): 2387-2391
Richter, J.E.; Long, J.F. 1995: Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study American Journal of Gastroenterology 90(3): 423-430
Melikoglu, M.; Fresko, I.; Mat, C.; Ozyazgan, Y.; Gogus, F.; Yurdakul, S.; Hamuryudan, V.; Yazici, H. 2005: Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study Journal of Rheumatology 32(1): 98-105
Olanow, C.W.; Alberts, M.J. 1987: Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease Advances in Neurology 45: 555-560
Antuono, P.G. 1995: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group Archives of Internal Medicine 155(16): 1766-1772
Magarò, M.; Altomonte, L.; Zoli, A.; Mirone, L.; Wielmarin, A.; Massari, M.; Destito, G.; Nazzari, M.; Psilogenis, M. 1989: Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo Minerva Dietologica E Gastroenterologica 35(1): 27-30
Weitbrecht, W.U.; Jansen, W. 1986: Primary degenerative dementia: therapy with Ginkgo biloba extract. Placebo-controlled double-blind and comparative study Fortschritte der Medizin 104(9): 199-202
Contu, A.; Marenco, G.; Pani, P.; Meloni, M.; Deriu, A.; Ortu, S.; Olmeo, N.; Schintu, G.M.; Daniotti, S. 1989: Preventive role of pirenzepine in gastric damage during cytostatic therapy. A controlled randomized double-blind study with placebo Minerva Dietologica E Gastroenterologica 35(4): 269-272
Da Costa, J.; Gomes, J.A.; Espirito Santo, J.; Queirós, M. 1987: Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study Journal of Rheumatology 14(4): 858-859
Maki, M.; Kobayashi, T.; Terao, T.; Ikenoue, T.; Satoh, K.; Nakabayashi, M.; Sagara, Y.; Kajiwara, Y.; Urata, M. 2000: Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group Thrombosis and Haemostasis 84(4): 583-590
Silver, D.E.; Sahs, A.L. 1971: Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease Transactions of the American Neurological Association 96: 307-308
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217
Rogers, S.L.; Doody, R.S.; Mohs, R.C.; Friedhoff, L.T. 1998: Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group Archives of Internal Medicine 158(9): 1021-1031
Appelberg, B.G.; Syvälahti, E.K.; Koskinen, T.E.; Mehtonen, O.P.; Muhonen, T.T.; Naukkarinen, H.H. 2001: Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study Journal of Clinical Psychiatry 62(6): 448-452
Alvarez, X.A.; Mouzo, R.; Pichel, V.; Pérez, P.; Laredo, M.; Fernández-Novoa, L.; Corzo, L.; Zas, R.; Alcaraz, M.; Secades, J.J.; Lozano, R.; Cacabelos, R. 1999: Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion Methods and Findings in Experimental and Clinical Pharmacology 21(9): 633-644
Caperton, E.M.; Heim-Duthoy, K.L.; Matzke, G.R.; Peterson, P.K.; Johnson, R.C. 1990: Ceftriaxone therapy of chronic inflammatory arthritis. a double-blind placebo controlled trial Archives of Internal Medicine 150(8): 1677-1682
Kiev, A. 1992: A double-blind, placebo-controlled study of paroxetine in depressed outpatients Journal of Clinical Psychiatry 53 Suppl: 27-29
Mulhern, B.; O'Connor, N.; Hillery, M.; Ward, O.C. 1982: A double blind placebo controlled study on the use of ketotifen in childhood asthma Irish Medical Journal 75(1): 25-28
Hargreaves, J. 1980: A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness Practitioner 224(1343): 547-550